The Potential of Zebrafish As a Model Organism for Improving the Translation of Genetic Anticancer Nanomedicines

Overview

Journal Genes (Basel)

Publisher MDPI

Date 2017 Nov 29

PMID 29182542

Citations 12

Authors

C Gutierrez-Lovera

A J Vazquez-Rios

J Guerra-Varela

L Sanchez

M de la Fuente

Affiliations

Soon will be listed here.

Abstract

In the last few decades, the field of nanomedicine applied to cancer has revolutionized cancer treatment: several nanoformulations have already reached the market and are routinely being used in the clinical practice. In the case of genetic nanomedicines, i.e., designed to deliver gene therapies to cancer cells for therapeutic purposes, advances have been less impressive. This is because of the many barriers that limit the access of the therapeutic nucleic acids to their target site, and the lack of models that would allow for an improvement in the understanding of how nanocarriers can be tailored to overcome them. Zebrafish has important advantages as a model species for the study of anticancer therapies, and have a lot to offer regarding the rational development of efficient delivery of genetic nanomedicines, and hence increasing the chances of their successful translation. This review aims to provide an overview of the recent advances in the development of genetic anticancer nanomedicines, and of the zebrafish models that stand as promising tools to shed light on their mechanisms of action and overall potential in oncology.

Citing Articles

Recent Advances of the Zebrafish Model in the Discovery of Marine Bioactive Molecules.

Liu C, Li J, Wang D, Liu J, Liu K, Li P Mar Drugs. 2024; 22(12).

PMID: 39728115 PMC: 11678508. DOI: 10.3390/md22120540.

Zebrafish live imaging: a strong weapon in anticancer drug discovery and development.

Zhan T, Song W, Jing G, Yuan Y, Kang N, Zhang Q Clin Transl Oncol. 2024; 26(8):1807-1835.

PMID: 38514602 DOI: 10.1007/s12094-024-03406-7.

Molecular mechanisms of anthracycline induced cardiotoxicity: Zebrafish come into play.

Moossavi M, Lu X, Herrmann J, Xu X Front Cardiovasc Med. 2023; 10:1080299.

PMID: 36970353 PMC: 10036604. DOI: 10.3389/fcvm.2023.1080299.

Zebrafish as a platform to evaluate the potential of lipidic nanoemulsions for gene therapy in cancer.

Cascallar M, Hurtado P, Lores S, Pensado-Lopez A, Quelle-Regaldie A, Sanchez L Front Pharmacol. 2022; 13:1007018.

PMID: 36386231 PMC: 9659613. DOI: 10.3389/fphar.2022.1007018.

Amino acid-modified PAMAM dendritic nanocarriers as effective chemotherapeutic drug vehicles in cancer treatment: a study using zebrafish as a cancer model.

Wu S, Chou H, Tsai H, Anbazhagan R, Yuh C, Yang J RSC Adv. 2022; 10(35):20682-20690.

PMID: 35517745 PMC: 9054295. DOI: 10.1039/d0ra01589j.

References

Howe K, Clark M, Torroja C, Torrance J, Berthelot C, Muffato M . The zebrafish reference genome sequence and its relationship to the human genome. Nature. 2013; 496(7446):498-503. PMC: 3703927. DOI: 10.1038/nature12111. View

Lin S, Zhao Y, Nel A, Lin S . Zebrafish: an in vivo model for nano EHS studies. Small. 2012; 9(9-10):1608-18. PMC: 4070293. DOI: 10.1002/smll.201202115. View

Zou D, Wang W, Lei D, Yin Y, Ren P, Chen J . Penetration of blood-brain barrier and antitumor activity and nerve repair in glioma by doxorubicin-loaded monosialoganglioside micelles system. Int J Nanomedicine. 2017; 12:4879-4889. PMC: 5511015. DOI: 10.2147/IJN.S138257. View

Rodriguez M, Pytlik R, Kozak T, Chhanabhai M, Gascoyne R, Lu B . Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non-Hodgkin lymphoma: report of the pivotal phase 2 study. Cancer. 2009; 115(15):3475-82. DOI: 10.1002/cncr.24359. View

Albadri S, Del Bene F, Revenu C . Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish. Methods. 2017; 121-122:77-85. DOI: 10.1016/j.ymeth.2017.03.005. View

Xu H, Dong X, Zhang Z, Yang M, Wu X, Liu H . Assessment of immunotoxicity of dibutyl phthalate using live zebrafish embryos. Fish Shellfish Immunol. 2015; 45(2):286-92. DOI: 10.1016/j.fsi.2015.04.033. View

Fuente M, Ravina M, Sousa-Herves A, Correa J, Riguera R, Fernandez-Megia E . Exploring the efficiency of gallic acid-based dendrimers and their block copolymers with PEG as gene carriers. Nanomedicine (Lond). 2012; 7(11):1667-81. DOI: 10.2217/nnm.12.51. View

Wagner D, Delk N, Lukianova-Hleb E, Hafner J, Farach-Carson M, Lapotko D . The in vivo performance of plasmonic nanobubbles as cell theranostic agents in zebrafish hosting prostate cancer xenografts. Biomaterials. 2010; 31(29):7567-74. PMC: 2924909. DOI: 10.1016/j.biomaterials.2010.06.031. View

Chang J, Ichihara G, Shimada Y, Tada-Oikawa S, Kuroyanagi J, Zhang B . Copper Oxide Nanoparticles Reduce Vasculogenesis in Transgenic Zebrafish Through Down-Regulation of Vascular Endothelial Growth Factor Expression and Induction of Apoptosis. J Nanosci Nanotechnol. 2015; 15(3):2140-7. DOI: 10.1166/jnn.2015.9762. View

10.

Jain P, Pawar R, Pandey R, Madan J, Pawar S, Lakshmi P . In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link?. Biotechnol Adv. 2017; 35(7):889-904. DOI: 10.1016/j.biotechadv.2017.08.003. View

11.

Zhuang S, Zhang Z, Zhang W, Bao L, Xu C, Zhang H . Enantioselective developmental toxicity and immunotoxicity of pyraclofos toward zebrafish (Danio rerio). Aquat Toxicol. 2014; 159:119-26. DOI: 10.1016/j.aquatox.2014.12.006. View

12.

Sukardi H, Ung C, Gong Z, Lam S . Incorporating zebrafish omics into chemical biology and toxicology. Zebrafish. 2010; 7(1):41-52. DOI: 10.1089/zeb.2009.0636. View

13.

Lam S, Chua H, Gong Z, Lam T, Sin Y . Development and maturation of the immune system in zebrafish, Danio rerio: a gene expression profiling, in situ hybridization and immunological study. Dev Comp Immunol. 2003; 28(1):9-28. DOI: 10.1016/s0145-305x(03)00103-4. View

14.

Evensen L, Johansen P, Koster G, Zhu K, Herfindal L, Speth M . Zebrafish as a model system for characterization of nanoparticles against cancer. Nanoscale. 2015; 8(2):862-77. DOI: 10.1039/c5nr07289a. View

15.

Geffroy B, Ladhar C, Cambier S, Treguer-Delapierre M, Brethes D, Bourdineaud J . Impact of dietary gold nanoparticles in zebrafish at very low contamination pressure: the role of size, concentration and exposure time. Nanotoxicology. 2011; 6(2):144-60. DOI: 10.3109/17435390.2011.562328. View

16.

Giannaccini M, Cuschieri A, Dente L, Raffa V . Non-mammalian vertebrate embryos as models in nanomedicine. Nanomedicine. 2013; 10(4):703-19. DOI: 10.1016/j.nano.2013.09.010. View

17.

Fent K, Weisbrod C, Wirth-Heller A, Pieles U . Assessment of uptake and toxicity of fluorescent silica nanoparticles in zebrafish (Danio rerio) early life stages. Aquat Toxicol. 2010; 100(2):218-28. DOI: 10.1016/j.aquatox.2010.02.019. View

18.

Lin S, Zhao Y, Xia T, Meng H, Ji Z, Liu R . High content screening in zebrafish speeds up hazard ranking of transition metal oxide nanoparticles. ACS Nano. 2011; 5(9):7284-95. PMC: 4136441. DOI: 10.1021/nn202116p. View

19.

Swain S, Sahu P, Beg S, Babu S . Nanoparticles for Cancer Targeting: Current and Future Directions. Curr Drug Deliv. 2016; 13(8):1290-1302. DOI: 10.2174/1567201813666160713121122. View

20.

Omidi Y, Hollins A, Drayton R, Akhtar S . Polypropylenimine dendrimer-induced gene expression changes: the effect of complexation with DNA, dendrimer generation and cell type. J Drug Target. 2005; 13(7):431-43. DOI: 10.1080/10611860500418881. View